Two Sigma’s Perovic expects AI to drive more biotech innovation in 2023

[ad_1]

Dusan Perovic, a partner with venture-capital firm Two Sigma Ventures, predicts that artificial intelligence in 2023 will drive more innovation in the life-sciences industry, helping companies discover drugs faster and ultimately reducing risks for biotechnology investors.


[ad_2]

Source link